Article
Development of a Functional Biomarker for Use in Cell-Based Therapy Studies in Seropositive Rheumatoid Arthritis.
Stem cells translational medicine - 1 May 2016
Shalev-Malul Gali, Soler David C, Ting Anthony E, Lehman Nicholas A, Barnboym Emma, McCormick Thomas S, Anthony Donald D, Lazarus Hillard M, Caplan Arnold I, Breitman Maya, Singer Nora G
Abstract excerpt
UNLABELLED: Cell-based therapy has potential therapeutic value in autoimmune diseases such as rheumatoid arthritis (RA). In RA, reduction of disease activity has been associated with improvement in the function of regulatory T cells (Treg) and attenuated responses of proinflammatory effector T cells (Teff). Mesenchymal stem cells (MSCs) and related multipotent adult progenitor cells (MAPC) have strong...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
